臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52937927 線上人數 : 522 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"huang t c"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 41-50 / 347 (共35頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-02-14T07:10:34Z	A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein–Barr Virus	SHAN-CHI YU; Ko K.-Y.; Teng S.-C.; Huang T.-C.; Lo H.-T.; Cheng C.-L.; Yao M.; Hong R.-L.; Chen C.-N.; Chen T.-C.; Yang T.-L.
臺大學術典藏	2022-02-14T07:10:33Z	Investigating early progression of Hodgkin lymphoma in a two-center analysis	Yu T.-C.; SHAN-CHI YU; Wang R.-C.; Lai S.-F.; Teng C.-L.J.; Lin J.-W.; Lin W.-L.; Huang T.-C.
臺大學術典藏	2022-02-07T07:49:00Z	Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏	2022-02-07T03:29:06Z	Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy	Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Lin C.-C.; Chen Y.-J.; Cheng A.-L.; CHIH-HUNG HSU
臺大學術典藏	2022-02-07T03:29:04Z	Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites	Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU
臺大學術典藏	2022-01-12T07:07:42Z	WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system	HSIN-AN HOU; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.
臺大學術典藏	2022-01-12T07:07:16Z	Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome	Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; HSIN-AN HOU; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; Tang J.-L.
臺大學術典藏	2022-01-12T07:07:11Z	ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden	Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; HSIN-AN HOU; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F.
臺大學術典藏	2022-01-12T07:07:09Z	Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	Wang Y.-W.; Tsai X.C.-H.; HSIN-AN HOU; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏	2022	Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy	Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Lin C.-C.; Chen Y.-J.; Cheng A.-L.; CHIH-HUNG HSU

顯示項目 41-50 / 347 (共35頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目